| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Subunit during Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Desensitization*
Reproductive Endocrine Unit and the Vincent Memorial Research Laboratories, Department of Medicine, and the Pediatric Endocrinology Unit of the Childrens Service, Massachusetts General Hospital Boston, Massachusetts 02114
the Divisions of Endocrinology and Adolescent and Young Adult Medicine, Department of Medicine, Childrens Hospital Medical Center Boston, Massachusetts 02115
Address all correspondence and requests for reprints to: Dr. Hal Landy, Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114.
Intact LH and free
-subunit (FAS) are differentially regulated during GnRH agonist (GnRHa)-induced pituitary desensitization; circulating levels of FAS rise, while LH levels decline. Increased steady state
and decreased LHβ mRNA levels in desensitized rat pituitaries suggest that differential regulation occurs at the level of subunit transcription. We assessed a renal contribution to these changes in serum hormone concentrations by studying LH and FAS levels in serum and urine in 15 pubertal children before and during long term GnRHa administration. Before GnRHa, serum LH and FAS were secreted in concordant pulses, and both responded briskly to exogenous GnRH. During GnRHa-induced pituitary desensitization, mean (±SEM) serum and urinary LH levels fell [11 ± 3 vs. 2 ± 0.2 IU/L (P < 0.01) and 39 ± 15 vs. 5 ± 1 IU/g creatinine (P < 0.05), respectively), and the LH response to exogenous GnRH was ablated (117 ± 20 vs. 1 ± 0.3 IU/L; P < 0.01). In contrast, despite suppression of FAS pulsatility, mean serum FAS levels rose during GnRHa treatment (204 ± 23 vs. 405 ± 50 ng/L; P < 0.01), and responsiveness to exogenous GnRH was maintained. Paradoxically, urinary FAS levels fell (3.2 ± 0.9 vs. 1.7 ± 0.4 µg/g creatinine; P < 0.05) as did its renal clearance (3.1 ± 0.5 vs. 1.3 ± 0.1 mL/min·m2; P < 0.05).
We conclude that during GnRHa-induced pituitary desensitization, the gonadotrope maintains the ability to respond to GnRH with FAS release, and the rise in serum FAS is due in part to its diminished renal clearance.
* This work was supported in part by NIH Grants HD-18169, HD-07277, RR-01066, RR-02172, and RR-08847. The data were presented in part at the 71st Annual Meeting of The Endocrine Society, Seattle, WA, June 1989.
Received April 23, 1990.
This article has been cited by other articles:
![]() |
B. D. Saunders, E. Sabbagh, W. W. Chin, and U. B. Kaiser Differential Use of Signal Transduction Pathways in the Gonadotropin-Releasing Hormone-Mediated Regulation of Gonadotropin Subunit Gene Expression Endocrinology, April 1, 1998; 139(4): 1835 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Lavoie, K. A. Martin, A. E. Taylor, W. F. Crowley, and J. E. Hall Exaggerated Free {alpha}-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 241 - 247. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |